FDA Authorizes Marketing Of First Eyeglass Lenses To Slow Progression Of Pediatric Myopia
View all comments(0)
Sept 25 (Reuters) - FDA:
FDA AUTHORIZES MARKETING OF FIRST EYEGLASS LENSES TO SLOW PROGRESSION OF PEDIATRIC MYOPIA - WEBSITE
FDA: AUTHORIZED MARKETING ESSILOR STELLEST EYEGLASS LENSES TO CORRECT MYOPIA IN CHILDREN 6-12 YEARS OLD AT INITIATION OF TREATMENT
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

U.S. April CPI Preview: Fed May Abandon Rate Cuts Until 2026?

Copper Prices Near All-Time Highs. Citi: If Strait of Hormuz Is Unblocked, Price Will Rise to $15,000 by Year-End

Tradingkey






Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.